Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Zealand Pharma A/S

ZLDPF
Current price
134.71 USD -1.18 USD (-0.87%)
Last closed 915.5 DKK
ISIN DK0060257814
Sector Healthcare
Industry Biotechnology
Exchange CO
Capitalization 63 722 304 727 DKK
Yield for 12 month +203.18 %
1Y
3Y
5Y
10Y
15Y
ZLDPF
21.11.2021 - 28.11.2021

Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The company offers Dasiglucagon, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon that is in Phase III clinical trials for treating congenital hyperinsulinism. The company is also developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. The company was incorporated in 1997 and is based in Søborg, Denmark. Address: Sydmarken 11, Søborg, Denmark, 2860

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

6 561.75 DKK

P/E ratio

Dividend Yield

Current Year

+341 766 326 DKK

Last Year

+103 676 074 DKK

Current Quarter

+34 029 270 DKK

Last Quarter

+15 044 027 DKK

Current Year

+322 649 472 DKK

Last Year

+103 676 074 DKK

Current Quarter

+24 568 555 DKK

Last Quarter

+10 460 729 DKK

Key Figures ZLDPF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -711 079 292 DKK
Operating Margin TTM -784.27 %
PE Ratio
Return On Assets TTM -7.38 %
PEG Ratio 0.31
Return On Equity TTM -12.8 %
Wall Street Target Price 6 561.75 DKK
Revenue TTM 366 875 263 DKK
Book Value 132.09 DKK
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 228 %
Dividend Yield
Gross Profit TTM 103 676 071 DKK
Earnings per share -11.41 DKK
Diluted Eps TTM -11.41 DKK
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -193.49 %

Dividend Analytics ZLDPF

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ZLDPF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation ZLDPF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 149.4133
Price Sales TTM 173.6893
Enterprise Value EBITDA -53.4149
Price Book MRQ 6.7605

Financials ZLDPF

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ZLDPF

For 52 weeks

273.58 DKK 969.1 DKK
50 Day MA 887.94 DKK
Shares Short Prior Month
200 Day MA 646.47 DKK
Short Ratio
Shares Short
Short Percent